StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) stock

BNRNasdaqServices-Medical Laboratories
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$12.50−0.24 (-1.88%)

Close on Nov 17, 2026Market cap $136.07MP/E –Yield –

Burning Rock Biotech profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was -10.3%, against -67.2% the year before. The highest annual figure on record is -10.3% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-10.3%+56.9
FY2024Dec 31, 2024-67.2%+54.4
FY2023Dec 31, 2023-121.6%+50.8
FY2022Dec 31, 2022-172.4%−15.6
FY2021Dec 31, 2021-156.9%−62.1
FY2020Dec 31, 2020-94.7%−50.4
FY2019Dec 31, 2019-44.3%+40.7
FY2018Dec 31, 2018-85.0%–

More Burning Rock Biotech figures

See a number that looks wrong?